Glenn D. Prestwich is Presidential Professor of Medicinal Chemistry and Presidential Special Assistant for Faculty Entrepreneurism. His research on phosphoinositide and lysolipid signaling, synthetic extracellular matrices for regenerative medicine, and glycosaminoglycan derivatives as safe and effective anti-inflammatory agents led to the co-founding of six companies including Echelon Biosciences, Glycosan BioSystems, and GlycoMira Therapeutics. He received the Governor’s Medal for Science and Technology for 2006, and was awarded the 1998 Paul Dawson Biotechnology Award and the 2008 Volwiler Research Award of the American Association of Colleges of Pharmacy. In 2010, he received the University of Utah Distinguished Scholarly and Creative Research Award, and the “Rooster Prize” of the International Society for Hyaluronan Science. During 34 years as a faculty member, he has published over 600 technical papers, patents, and book chapters, and has trained over 125 postgraduate scientists. He is also a commercially-rated pilot and sings first tenor in the Utah Symphony Chorus.